Maravai LifeSciences Holdings, Inc. (MRVI) 追踪市盈率为负值 -3.4, 表示公司目前在过去十二个月 (TTM) 基础上处于亏损状态。 追踪盈利收益率为 -29.31%.
本页证实的标准:
SharesGrow 综合评分： 41/100 其中 1/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2018 | -149.8 | 0.00 | 18.39 | 21.45 | 1.96% |
| 2019 | -340.0 | 4.65 | 20.40 | 20.15 | - |
| 2020 | 35.3 | 0.00 | 30.63 | 9.54 | - |
| 2021 | 26.4 | -0.34 | 15.24 | 6.02 | - |
| 2022 | 8.5 | 1.70 | 3.45 | 2.13 | - |
| 2023 | -7.3 | 0.05 | 2.07 | 2.99 | - |
| 2024 | -5.2 | -0.31 | 2.31 | 2.90 | - |
| 2025 | -3.6 | 0.27 | 2.22 | 2.54 | - |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2018 | $-0.20 | $123.83M | $-17.73M | -14.3% |
| 2019 | $-0.05 | $143.14M | $-5.2M | -3.6% |
| 2020 | $0.70 | $284.1M | $76.89M | 27.1% |
| 2021 | $1.82 | $799.24M | $469.25M | 58.7% |
| 2022 | $1.92 | $883M | $490.66M | 55.6% |
| 2023 | $-0.90 | $288.95M | $-119.03M | -41.2% |
| 2024 | $-1.05 | $259.19M | $-144.85M | -55.9% |
| 2025 | $-0.91 | $185.74M | $-130.77M | -70.4% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $-0.18 | $-0.25 – $-0.14 | $204.75M | $204.34M – $205.06M | 6 |
| 2027 | $-0.15 | $-0.22 – $-0.10 | $220.91M | $218.84M – $224.22M | 6 |
| 2028 | $-0.12 | $-0.15 – $-0.10 | $235.92M | $235.26M – $236.58M | 2 |
| 2029 | $-0.17 | $-0.17 – $-0.16 | $247.15M | $244.35M – $251.27M | 1 |
| 2030 | $-0.15 | $-0.15 – $-0.15 | $262.65M | $259.68M – $267.03M | 1 |
